Search results
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 2 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
This is the best way to protect yourself
Weston Forum· 5 days agoAlong with hazel and birch, poplar pollen is one of the most common allergens. It is easily confused with the cotton-like wool of poplar. You can find...
Quercetin: The Immune-Supporting Antioxidant You're About To See Everywhere
MindBodyGreen· 1 day agoMany factors in modern life can weaken the immune system (lack of sleep, high sugar consumption,...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
WKBN 27 Youngstown· 5 days ago- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory ...
They couldn't move their hands for years. A new device offers the promise of mobility.
USA Today· 2 days agoFor Melanie Reid, 67, the biggest change was being able to pull her hair back into a ponytail by...